Global Valsartan Tablet Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028

The global valsartan tablet market is anticipated to grow at a significant CAGR of 6.2% during the forecast period (2022-2028). Excessive salt consumption, a diet high in saturated fat and trans fats, and an insufficient intake of fruits and vegetables are all modifiable risk factors for hypertension, as are physical inactivity, cigarette and alcohol use, and being overweight or obese. Non-modifiable risk factors include a family history of hypertension, age over 65, and co-existing diseases such as diabetes or kidney disease.  Simultaneously increasing the market of valsartan tablet. For instance, Novartis India Ltd offers Diovan 80 Tablet, It’s used to treat hypertension and heart failure. Lowering blood pressure can help avoid heart attacks and strokes in the future. This medicine can also assist diabetics in maintaining renal function.

Valsartan is an angiotensin II receptor antagonist that blocks the angiotensin II receptor type I (AT1), raises angiotensin II levels in the blood, stimulates the unblocked AT2 receptor, and counteracts the effects of the AT1 receptor on blood vessel dilation and blood pressure reduction. Valsartan pills are primarily prescribed for the treatment of mild to moderate primary hypertension.

According to World Health Organization, Hypertension, often known as high blood pressure, is a serious medical condition that raises the risk of heart, brain, kidney, and other disorders dramatically. Hypertension affects an estimated 1.28 billion persons aged 30 to 79 globally, with the majority (two-thirds) residing in low- and middle-income nations. An estimated 46% of persons with hypertension are completely ignorant of their illness. Only around half of those with hypertension are aware of it and receive treatment (42%). Only about a fifth of people with hypertension (21%) has it under control. Hypertension is one of the top causes of death globally.  Between 2010 and 2030, one of the global non-communicable disease targets is to lower the prevalence of hypertension by 33%. With such a huge customer base, the market of the valsartan tablet market is going to propel in the forecasted period.

Some major players in the market include Jubilant Cadista Pharmaceuticals Inc., Lupin Ltd., Mylan N.V., Novartis India Ltd, and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, Teva Pharmaceutical Industries Ltd. offers Teva-Valsartan in four different strengths, Valsartan is a member of the angiotensin II receptor blocker family of drugs. These drugs are used to treat mild to moderate hypertension. Valsartan is also used to treat chronic heart failure and to lower the risk of death following a heart attack in those who cannot take an angiotensin-converting enzyme inhibitor.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Jubilant Cadista Pharmaceuticals Inc., Lupin Ltd., Mylan N.V., Novartis India Ltd, Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Valsartan Tablet Market Report by Segment

By Type

• Valsartan/Hydrochlorothiazide
• Valsartan/Amlodipine
• Valsartan/Amlodipine/Hydrochlorothiazide
• Valsartan/Sacubitril

By Application

• High Blood Pressure
• Heart Failure

Global Valsartan Tablet Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa